Efficient Inhibition of Human Papillomavirus Infection by L2 Minor Capsid-Derived Lipopeptide

mBio - United States
doi 10.1128/mbio.01834-19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Subcellular Trafficking of the Papillomavirus Genome During Initial Infection: The Remarkable Abilities of Minor Capsid Protein L2

2017English

Production and Characterization of Virus-Like Particles of Grapevine Fanleaf Virus Presenting L2 Epitope of Human Papillomavirus Minor Capsid Protein

BMC Biotechnology
Biotechnology
2019English

Protection Against Heterologous Human Papillomavirus Challenge by a Synthetic Lipopeptide Vaccine Containing a Broadly Cross-Neutralizing Epitope of L2

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Human Papillomavirus Type 18 Chimeras Containing the L2/L1 Capsid Genes From Evolutionarily Diverse Papillomavirus Types Generate Infectious Virus

Virus Research
Cancer ResearchVirologyInfectious Diseases
2011English

Maturation of the Human Papillomavirus 16 Capsid

mBio
VirologyMicrobiology
2014English

Chimeric Human Papillomavirus Type 16 (HPV-16) L1 Particles Presenting the Common Neutralizing Epitope for the L2 Minor Capsid Protein of HPV-6 and HPV-16

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2003English

Human Papillomavirus Infection

JAMA - Journal of the American Medical Association
Medicine
2007English

The Clearance of Oral High-Risk Human Papillomavirus Infection Is Impaired by Long-Term Persistence of Cervical Human Papillomavirus Infection

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2014English

Α-Defensin HD5 Inhibits Human Papillomavirus 16 Infection via Capsid Stabilization and Redirection to the Lysosome

mBio
VirologyMicrobiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy